Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience
The therapeutic approach to JIA is sometimes very troublesome and progression to erosive polyarthritis may occur in all JIA categories. Only Methotrexate has shown efficacy and safety in a large controlled trial. Nevertheless, in many cases, drug resistance or intolerance has led to try other therap...
Saved in:
Main Authors: | F. Fantini (Author), M Gattinara (Author), I. Pontikaki (Author), V. Gerloni (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008) -
Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
by: Salmaso A, et al.
Published: (2008) -
BIOLOGIC THERAPY IN PEDIATRIC RHEUMATOLOGY
by: A. A. Baranov, et al.
Published: (2011) -
BIOLOGIC THERAPY IN PEDIATRIC RHEUMATOLOGY
by: A. A. Baranov, et al.
Published: (2011) -
ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008)